Announcement of Q&As for PAR-13-250 "NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44)"

Notice Number: NOT-AI-14-038

Key Dates
Release Date: February 24, 2014

Related Announcements
PAR-13-250

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to announce a Questions and Answers website for PAR-13-250 "NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44)": http://www.niaid.nih.gov/researchfunding/qa/Pages/PAR-13-250.aspx.

Inquiries

Please direct all inquiries to:

Natalia Kruchinin, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Phone: 301-496-8666
Email: kruchininn@niaid.nih.gov

 

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.